Spots Global Cancer Trial Database for dcis
Every month we try and update this database with for dcis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast | NCT00556907 | Breast Cancer | Intraoperative ... Intraoperative ... | 40 Years - | University of Southern California | |
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | NCT00669747 | Ductal Carcinom... | Carboplatin i.d... Carboplatin i.d... Normal Saline | 18 Years - | Windy Hill Medical, Inc. | |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer | NCT03936478 | Breast Cancer DCIS LCIS | MRIdian Radiati... | 40 Years - | University of Wisconsin, Madison | |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence | NCT06388304 | Breast Cancer DCIS | THRIVE Online P... | 21 Years - | University of Colorado, Boulder | |
Impact of Radiation Therapy on Breast Conservation in DCIS | NCT02248662 | DCIS | 21 Years - | Dana-Farber Cancer Institute | ||
DC Vaccine for Patients With Ductal Carcinoma In Situ | NCT02061332 | Breast Cancer DCIS | HER-2 Pulsed De... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ | NCT04722692 | DCIS Breast Cancer Breast Neoplasm... Sentinel Lymph ... | Delayed SLND Late SLND | 18 Years - | Uppsala University | |
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy | NCT00146536 | Breast Neoplasm... | 20 Years - | Dana-Farber Cancer Institute | ||
Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy | NCT01185145 | Breast Cancer | Breast Brachyth... Intensity Modul... | 40 Years - | Rocky Mountain Cancer Centers | |
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients | NCT03931928 | Breast Cancer DCIS | (Z)-Endoxifen s... (Z)-Endoxifen s... | 18 Years - | Robert Bosch Gesellschaft für Medizinische Forschung mbH | |
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up | NCT01357772 | Carcinoma, Intr... Recurrence, Loc... Breast Neoplasm... Atypical Hyperp... | Tamoxifen placebo | 18 Years - 75 Years | Ente Ospedaliero Ospedali Galliera | |
Intraoperative Radiation Therapy (IORT) in DCIS | NCT03216421 | Breast Cancer Ductal Carcinom... | Quality of Life... | 18 Years - | Columbia University | |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ | NCT04722692 | DCIS Breast Cancer Breast Neoplasm... Sentinel Lymph ... | Delayed SLND Late SLND | 18 Years - | Uppsala University | |
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast | NCT03878342 | DCIS Breast Cancer Low Risk DCIS Breast Conservi... Radiotherapy Om... | Radiotherapy No Radiotherapy | 50 Years - | UNICANCER | |
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy | NCT00146536 | Breast Neoplasm... | 20 Years - | Dana-Farber Cancer Institute | ||
The Prone Breast Radiation Therapy Trial | NCT01815476 | Ductal Carcinom... Invasive Breast... | Radiation Thera... | - | Toronto Sunnybrook Regional Cancer Centre | |
Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors | NCT02856503 | Breast Cancer Invasive Breast... Ductal Carcinom... | Vitamin D3 | 18 Years - | University of Miami | |
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery | NCT03113825 | Primary Invasiv... Carcinoma Breas... Breast Cancer F... Carcinoma, Duct... Stage II Breast... Stage I Breast ... Stage III Breas... | Investigational... AVB-620 | 18 Years - | Avelas Biosciences, Inc. | |
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS | NCT06217458 | DCIS Breast Carcinom... Calcification | Contrast Enhanc... | 18 Years - 99 Years | Clinical Hospital Center Rijeka | |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ | NCT05218044 | Ductal Carcinom... | Cryoablation | 18 Years - | Glendale Adventist Medical Center d/b/a Adventist Health Glendale | |
RAPID: Randomized Trial of Accelerated Partial Breast Irradiation | NCT00282035 | Breast Cancer | APBI utilizing ... Whole breast ir... | 40 Years - | Ontario Clinical Oncology Group (OCOG) | |
Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs | NCT04170920 | Breast Cancer DCIS | LifeExtend-AI | 18 Years - | Indiana University | |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence | NCT06388304 | Breast Cancer DCIS | THRIVE Online P... | 21 Years - | University of Colorado, Boulder | |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence | NCT06388304 | Breast Cancer DCIS | THRIVE Online P... | 21 Years - | University of Colorado, Boulder | |
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS | NCT02926911 | DCIS Ductal Carcinom... | Surgery Active Monitori... | 40 Years - 99 Years | Alliance Foundation Trials, LLC. | |
MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ | NCT00586326 | DCIS | MammoSite Radia... | 45 Years - | Hologic, Inc. | |
Impact of Radiation Therapy on Breast Conservation in DCIS | NCT02248662 | DCIS | 21 Years - | Dana-Farber Cancer Institute | ||
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients | NCT03931928 | Breast Cancer DCIS | (Z)-Endoxifen s... (Z)-Endoxifen s... | 18 Years - | Robert Bosch Gesellschaft für Medizinische Forschung mbH | |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ | NCT05218044 | Ductal Carcinom... | Cryoablation | 18 Years - | Glendale Adventist Medical Center d/b/a Adventist Health Glendale | |
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy | NCT01185132 | Breast Cancer | accelerated par... accelerated par... | 40 Years - | Rocky Mountain Cancer Centers | |
Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer | NCT05436808 | Breast Cancer Breast Cancer F... DCIS Stage II Breast... Stage I Breast ... | Partial Chest W... | 18 Years - | Stony Brook University | |
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up | NCT01357772 | Carcinoma, Intr... Recurrence, Loc... Breast Neoplasm... Atypical Hyperp... | Tamoxifen placebo | 18 Years - 75 Years | Ente Ospedaliero Ospedali Galliera | |
Ruxolitinib for Premalignant Breast Disease | NCT02928978 | Ductal Carcinom... Atypical Lobula... Atypical Ductal... Lobular Carcino... | Ruxolitinib Placebo (for Ru... | 18 Years - | Baylor Breast Care Center | |
Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS) | NCT00890994 | Breast Cancer | 25 Years - 90 Years | Mayo Clinic | ||
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS | NCT06217458 | DCIS Breast Carcinom... Calcification | Contrast Enhanc... | 18 Years - 99 Years | Clinical Hospital Center Rijeka | |
Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity | NCT04245150 | DCIS Invasive Breast... | Stool sample Skin Swab Sampl... | 18 Years - | Case Comprehensive Cancer Center | |
Women Informed to Screen Depending on Measures of Risk (Wisdom Study) | NCT02620852 | Breast Cancer S... Breast Carcinom... Breast Cancer | Complete a heal... Provide a saliv... Screening advic... Screening advic... | 30 Years - 74 Years | University of California, San Francisco | |
Tumor: Breast Ratio Study | NCT02216136 | Breast Cancer LCIS DCIS | 18 Years - 72 Years | Washington University School of Medicine | ||
BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB) | NCT01961531 | Breast Cancer | Accuboost APBI | 50 Years - | Brown University | |
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | NCT00496808 | Ductal Carcinom... | Herceptin (Tras... | - | M.D. Anderson Cancer Center | |
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | NCT00496808 | Ductal Carcinom... | Herceptin (Tras... | - | M.D. Anderson Cancer Center | |
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer | NCT04084730 | Invasive Ductal... Invasive Ductal... DCIS DCIS Grade 1 DCIS Grade 2 Breast Cancer | Accelerated Par... | 45 Years - | Memorial Sloan Kettering Cancer Center | |
Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure | NCT00380952 | Breast Cancer | Dune Device | 18 Years - | Dune Medical Devices | |
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast | NCT00165256 | Ductal Carcinom... | Observation | 18 Years - | Dana-Farber Cancer Institute | |
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ | NCT01060345 | Ductal Carcinom... | Polyphenon E | 18 Years - | University of Chicago | |
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast | NCT03878342 | DCIS Breast Cancer Low Risk DCIS Breast Conservi... Radiotherapy Om... | Radiotherapy No Radiotherapy | 50 Years - | UNICANCER | |
Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer | NCT05436808 | Breast Cancer Breast Cancer F... DCIS Stage II Breast... Stage I Breast ... | Partial Chest W... | 18 Years - | Stony Brook University | |
Tumor: Breast Ratio Study | NCT02216136 | Breast Cancer LCIS DCIS | 18 Years - 72 Years | Washington University School of Medicine | ||
RAPID: Randomized Trial of Accelerated Partial Breast Irradiation | NCT00282035 | Breast Cancer | APBI utilizing ... Whole breast ir... | 40 Years - | Ontario Clinical Oncology Group (OCOG) | |
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS | NCT02926911 | DCIS Ductal Carcinom... | Surgery Active Monitori... | 40 Years - 99 Years | Alliance Foundation Trials, LLC. | |
Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery | NCT03535506 | DCIS | Palbociclib | 18 Years - | Georgetown University | |
Molecular Analysis of the Sloane Project | NCT05868252 | DCIS LCIS Atypical Ductal... Atypical Lobula... | - | King's College London | ||
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | NCT00496808 | Ductal Carcinom... | Herceptin (Tras... | - | M.D. Anderson Cancer Center | |
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) | NCT04797299 | DCIS | 46 Years - | Ontario Clinical Oncology Group (OCOG) | ||
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery | NCT03113825 | Primary Invasiv... Carcinoma Breas... Breast Cancer F... Carcinoma, Duct... Stage II Breast... Stage I Breast ... Stage III Breas... | Investigational... AVB-620 | 18 Years - | Avelas Biosciences, Inc. |